A new study, released law month, says a commonly-used test for ovarian cancer doesn’t increase a woman’s chance of survival and may in fact create other health problems. This study was from UAB in Birmingham, Ala. and elsewhere. The study, which was published in the June 9th issue of the Journal of the American Medical Association, looked at the use of transvaginal ultrasound and a blood test doctors use to find an early sign of ovarian cancer and other tumors called CA-125. The two diagnostic tests are often provided by doctors annually or given to women who request screening.
Source: Birmingham News
Contact us today for a free legal consultation with an experienced attorney.
Fields marked *may be required for submission.
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.